Predictors for the outcomes of patients with estrogen receptor-positive, HER2-negative advanced breast cancer treated using palbociclib plus endocrine therapy.
| Autor: | Yutaka YAMAMOTO, Ryohei OGATA, Naoki KANOMATA, Emi KISHINO, Takuya MORIYA, Junichi KUREBAYASHI |
|---|---|
| Zdroj: | Kawasaki Medical Journal; 2020, Vol. 46, p135-143, 9p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|